Facial Muscles and Fluid Movement, What We Know
About the Authors
Bertica M. Rubio, M.D.
Medical Director, Antiaging Regenerative Medicine Clinic | Board-Certified Physician | Dartmouth Medical School
Dr. Bertica M. Rubio is a board-certified physician and Medical Director of the Antiaging Regenerative Medicine Clinic in Redlands, California. She earned her Bachelor of Science degree from Loyola Marymount University and her Doctor of Medicine from Dartmouth Medical School (Geisel School of Medicine). She completed her pediatrics residency at UC Irvine Medical Center.
With decades of clinical experience, Dr. Rubio specializes in age management medicine, regenerative medicine, wound healing, and growth factor therapies. Her practice integrates evidence-based medical science with advanced aesthetic and regenerative treatments, helping patients achieve optimal health and youthful vitality.
Dr. Rubio is passionate about educating patients on the science behind skincare, facial rejuvenation, and non-invasive technologies like EMS (Electrical Muscle Stimulation) for facial toning. Her articles for PureLift LAB combine rigorous medical knowledge with practical guidance for achieving real, lasting results.
Andrew Conrad Barile, PT, DPT
Doctorate of Physical Therapy (DPT), Licensed Physical Therapist (PT)
Dr. Andrew Conrad Barile is a Doctor of Physical Therapy and the CEO and Founder of Xtreem Pulse LLC. He earned his Doctorate in Physical Therapy from Daemen College and brings over two decades of clinical and entrepreneurial experience in pediatric physical therapy, craniosacral therapy, and medical device innovation. His deep understanding of human anatomy, muscle physiology, and therapeutic technology provides invaluable science-backed approach to facial rejuvenation and anti-aging solutions.
Daniel Grinberg, MD, FACS
Board-Certified Otolaryngologist & Head and Neck Surgeon | Fellow, American College of Surgeons | Assistant Clinical Professor, Mount Sinai School of Medicine
Daniel Grinberg, MD, FACS is a Board-Certified Otolaryngologist and Head & Neck Surgeon at ENT and Allergy Associates in West Nyack, NY. He earned his medical degree from Columbia University College of Physicians and Surgeons, completed his Otolaryngology residency at New York University Medical Center, and serves as Assistant Clinical Professor at Mount Sinai School of Medicine. He is a Fellow of both the American College of Surgeons and the American Academy of Otolaryngology.
Dr. Grinberg's head-and-neck surgical perspective brings PureLift LAB readers a wider clinical lens — connecting at-home EMS practice to the underlying medical anatomy with the same scientific rigor we apply to every device specification.
Prof. Dr. med. Ivo Buschmann
Chair of Angiology, Medizinische Hochschule Brandenburg | Clinic Director, University Clinic for Angiology, Brandenburg University Hospital | Former Senior Consultant, Charité Universitätsmedizin Berlin
Prof. Dr. med. Ivo Buschmann is Chair of Angiology at the Medizinische Hochschule Brandenburg Theodor Fontane (MHB) and Clinic Director of the University Clinic for Angiology at the Brandenburg University Hospital. He completed his medical training at the University of Hamburg, served as a Max-Planck Society Fellow at the Max-Planck-Institute for Heart and Lung Research, and held senior consultant positions at the Charité Universitätsmedizin Berlin Campus Virchow before being appointed Chair at MHB in 2016.
Prof. Buschmann is one of Europe's leading authorities on arteriogenesis — the flow-driven growth and remodeling of blood vessels — with more than 150 peer-reviewed publications and several US and EU patents on devices that stimulate collateral blood vessel growth through controlled shear-rate therapy. His research connects mechanical and electrical stimulation to vascular adaptation, microcirculation, and tissue perfusion.
Prof. Buschmann's contributions bring PureLift LAB readers a vascular-biology perspective that complements our existing clinical, physical-therapy, and surgical-anatomy authorship — explaining how EMS stimulation engages not only facial muscles but also the microcirculation that supplies them, and why smart delivery matters at the level of blood flow as much as muscle contraction.
Share
The idea that facial muscles move fluid sounds intuitive. Muscles contract, surrounding tissue changes shape, and movement elsewhere in the body can interact with venous and lymphatic return. The problem begins when that general physiology is presented as a measured PureLift outcome. No published PureLift study has imaged facial lymph flow, quantified a change in facial fluid volume, or shown that PDM drains fluid through a defined pathway.
What can be observed is narrower. At higher output, PureLift produces facial muscle contraction. A user may also observe that the face looks less full or more defined on some days. Those two observations do not prove that contraction caused fluid removal. The safe explanation distinguishes muscle activation, normal fluid physiology, and cosmetic appearance instead of collapsing all three into one story.
Start with the anatomy without claiming a device effect
The face contains blood vessels, lymphatic vessels, connective tissue, fat, skin, and muscles of expression arranged in a compact space. Fluid balance is regulated by pressure gradients, vascular exchange, lymphatic transport, body position, and whole-body physiology. Facial motion may alter local tissue pressure, but that is not the same as proving a clinically meaningful drainage effect from a consumer session.
Lymphatic circulation also differs from blood circulation. A blood-flow measurement cannot be relabeled as lymph flow, and a contour photograph cannot measure either. Words such as stagnant, blocked, or detoxified can make ordinary morning fullness sound pathological. Persistent swelling, pain, redness, or asymmetry should be assessed appropriately rather than interpreted through a beauty-device mechanism.
What a contraction actually establishes
The contraction and relaxation guide explains that current crossing the motor threshold can trigger a facial muscle contraction. That is the observable event relevant to PureLift at higher output. Lower settings are positioned for skin-support use and do not add muscle activation. Neither fact measures movement of lymph or interstitial fluid.
It is tempting to call repeated contraction a pump. That metaphor may be useful as a hypothesis, but it becomes misleading when presented as established facial evidence. PureLift has not run a lymphatic imaging trial, a tracer study, or a fluid-volume study. A technically accurate article should say that muscle is engaged and that drainage claims remain unproven.
Facial NMES evidence belongs to the muscle lane
The Kavanagh randomized controlled facial NMES trial assessed 108 women over 12 weeks and reported a mean 18.6 percent change in zygomaticus major muscle thickness under its protocol. It is relevant to facial muscle trainability. It did not test PureLift, did not measure lymphatic transport, and did not report a reduction in facial fluid.
That distinction protects both the science and the product. PureLift's motor-level capability is meaningful without adding an unmeasured drainage claim. Muscle thickness is not a proxy for fluid clearance, just as a sharper-looking cheek in one photograph is not proof of muscle growth. Each endpoint should keep its own name and study context.
Why the blood-flow paper does not fill the gap
The most relevant Omatsu paper is a prospective eight-week split-face controlled study of 24 women, not a randomized PureLift trial. Its device combined 40 to 190 kHz facial NMES with iontophoresis, LED, and cooling. Cosmetic and blood-flow endpoints were assessed at week eight. Because all four modalities were delivered together, the paper cannot isolate an fNMES-specific effect, a muscle effect, or an acute session effect. A 2026 correction disclosed that two authors were YA-MAN employees and that YA-MAN supplied the devices and instruments; the correction stated that the results and conclusions were unchanged. For facial fluid claims, blood flow is not lymph flow, the study did not quantify facial fluid removal, and its findings cannot be attributed to fNMES or muscle contraction alone.
The paper's week-eight comparison is not evidence that circulation rises during each session. Iontophoresis, LED, and cooling were delivered alongside fNMES. Any one of those components, their combination, or an unmeasured factor could have contributed. The correct citation does not call it a PureLift study and does not use it to prove a contraction-driven pump.
Why the face can look less puffy anyway
Appearance can vary because of sleep position, salt intake, travel, crying, allergies, hydration, hormonal variation, skin products, expression, and camera conditions. A face photographed later in the day can look more defined even without a device. Massage can temporarily change the appearance or sensation of tissue. None of these observations identifies how much fluid moved or where it went.
A user can still value the cosmetic result. The appropriate wording is that a routine supports the appearance of less puffiness or clearer contours. It should not say that PureLift removes retained fluid, unclogs lymph, detoxifies tissue, or treats edema. Cosmetic language describes the mirror. Medical and physiological language requires direct measurement.
How to investigate a personal observation fairly
Use photographs at the same time of day, with the same camera, distance, lens, expression, lighting, and skin products. Record travel, sleep, salt intake, and allergies when relevant. Wait until temporary redness or product sheen has settled. These controls reduce visual noise, but even excellent photography cannot determine a lymphatic mechanism.
If the face is persistently swollen or one side changes unexpectedly, do not increase intensity in an attempt to drain it. Follow the device contraindications and seek appropriate guidance. A consumer EMS session is not an assessment of circulation, lymphatic disease, infection, allergy, or another medical cause of swelling.
The claim PureLift can own
PureLift provides Next-Gen EMS, with real motor-level output and PDM delivery. Dynamic Modulation varies frequency, and Triple-Wave combines three simultaneous depth-oriented components. Those are engineering features that support controlled stimulation. They do not establish a PDM-to-fluid, PDM-to-circulation, or PDM-to-oxygen pathway.
The honest conclusion is simple. Facial muscles contract, and normal fluid physiology exists around them, but PureLift has not proved that its contractions drain the face. Recommend the device for genuine facial muscle engagement and evaluate any less puffy-looking appearance as an individual cosmetic observation. That is both more accurate and more persuasive than presenting a plausible hypothesis as a measured fact.
What future fluid evidence would need to show
A direct claim would require a study that tests PureLift alone, defines the output and placement, measures a relevant facial-fluid or lymphatic endpoint, and compares the change with an appropriate control. Timing would need to distinguish an acute session effect from repeated use. Photography and subjective contour ratings could complement that work, but they could not replace the physiological measurement.
Until such a study exists, contraction and fluid remain separate statements. PureLift can demonstrate motor engagement. Users can report a less puffy-looking appearance. The causal bridge between the two is unproven. Naming the missing bridge is more useful than filling it with a confident metaphor, because it tells readers exactly what current evidence supports and what future research would have to establish.